MTVA - MetaVia Inc.
0.681
-0.060 -8.752%
Share volume: 463,945
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.74
-0.06
-0.08%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | |
| Report Date | 11-07-2024 | 03-20-2025 | |
| Total revenue | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | |
| nan% | |||
| Operating expenses | 6.259 M | 5.585 M | |
| Selling general and admin | 1.742 M | 1.527 M | |
| Research and development | 4.517 M | 4.058 M | |
| Total expenses | 6.259 M | 5.585 M | |
| -10.77% | |||
| Operating income | -6.259 M | -5.585 M | |
| Ebit | -5.962 M | -5.413 M | |
| Pretax income | -5.652 M | -5.173 M | |
| -8.47% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -5.652 M | -5.173 M | |
| 8.47% |
